XML 37 R19.htm IDEA: XBRL DOCUMENT v3.21.2
GOODWILL AND INTANGIBLE ASSETS
 12 Months Ended
Oct. 01, 2021
Goodwill and Intangible Assets Disclosure [Abstract]  
GOODWILL AND INTANGIBLE ASSETS GOODWILL AND INTANGIBLE ASSETS
    The following table reflects goodwill by reportable segment:
(In millions)
Medical
Industrial
Total
Balance at October 2, 2020$174.4 $118.7 $293.1 
Other
(0.2)(0.2)(0.4)
Foreign currency translation adjustments
(0.3)(0.2)(0.5)
Balance at October 1, 2021$173.9 $118.3 $292.2 

    The following table reflects the gross carrying amount and accumulated amortization of the Company’s finite-lived intangible assets included in other assets in the consolidated balance sheets:
October 1, 2021October 2, 2020
(In millions)
Gross Carrying Amount
Accumulated Amortization
Net Carrying AmountGross Carrying Amount
Accumulated Amortization
Net Carrying Amount
Acquired existing technology
$74.2 $(45.5)$28.7 $74.9 $(37.5)$37.4 
Patents, licenses and other
12.8 (10.9)1.9 12.8 (9.7)3.1 
Customer contracts and supplier relationship
51.1 (31.0)20.1 51.2 (24.2)27.0 
Total intangible assets
$138.1 $(87.4)$50.7 $138.9 $(71.4)$67.5 
    Amortization expense for intangible assets was $16.8 million, $17.2 million and $15.7 million in fiscal years 2021, 2020 and 2019, respectively. The Company recognized intangible asset impairment charges of $0.0 million, $2.8 million, and $4.8 million in fiscal years 2021, 2020, and 2019, respectively, which are included in the consolidated statements of operations under impairment of intangible assets. These impairment charges related primarily to the Company's Medical reporting segment.
    As of October 1, 2021, the estimated future amortization expense of intangible assets with finite lives is as follows:
(In millions)
Fiscal years:
2022$14.7 
202313.6 
20249.2 
20253.0 
20263.0 
Thereafter
7.2 
Total
$50.7